What Do Panmyelosis and Hypercellularity Mean in PV?

When your bone marrow biopsy report for polycythemia vera (PV) says “hypercellular” and “panmyelosis,” it means that your bone marrow contains a higher proportion of blood-forming cells than expected for your age, and that it is showing increased production across all three major blood cell lines (red cells, white cells, and platelets) ^[1].

While reading a pathology report can be intimidating, these are standard descriptive terms. Here is exactly what your pathologist is describing and how these findings fit into your overall diagnosis.

Hypercellularity: A Crowded Bone Marrow

Inside your bones, the marrow is made up of a mix of blood-forming cells (the “factories”) and fat cells. As we get older, the number of blood-forming cells naturally decreases and is gradually replaced by more fat.

When a pathologist describes your bone marrow as hypercellular for age, they mean that the marrow contains a higher percentage of blood-forming cells—and less fat—than would normally be expected for someone of your age ^[1][2]. In polycythemia vera, the marrow is highly active, resulting in this increased cellularity.

Panmyelosis: Increased Production Across Three Blood Lines

The prefix “pan-” means all, and “myelo-” refers to the bone marrow. While polycythemia vera is most famous for causing an excess of red blood cells, panmyelosis means the marrow is showing increased proliferation (growth and production) across all three major blood cell lines ^[1][3].

If you have panmyelosis, your bone marrow is showing an abnormal expansion of:

• Erythroid precursors: The cells that mature into red blood cells.
• Granulocytic precursors: The cells that mature into granulocytes (a type of white blood cell).
• Megakaryocytes: The large cells that create blood platelets.

This “trilineage” (three-line) overproduction is a characteristic finding in polycythemia vera ^[4]. However, it is important to know that while your bone marrow is busy producing all three types of cells, this does not mean all three will be elevated on your routine peripheral blood tests. Many patients with panmyelosis only have high red blood cells, while others may also have elevated white blood cell and platelet counts.

Why These Words Matter for Your Diagnosis

Pathologists use these specific terms because they are looking for patterns established by the World Health Organization (WHO) and the International Consensus Classification (ICC). Having a hypercellular bone marrow with panmyelosis—along with specific physical appearances of the megakaryocytes—is a “major criterion” for diagnosing PV ^[5][6]. In this context, “major criterion” does not mean your disease is severe; it simply means it is one required item in a formal set of diagnostic rules.

However, a biopsy showing these features does not confirm the disease entirely on its own ^[7]. Because this marrow pattern can sometimes be seen in other conditions, your care team will combine this biopsy evidence with a broader clinical picture:

• Blood Counts: Evaluating your hemoglobin and hematocrit levels over time.
• Molecular Testing: Checking for genetic variants in the JAK2 gene (most commonly the JAK2 V617F mutation), which are present in the vast majority of PV cases ^[8]. However, a negative test does not entirely rule out PV.
• Erythropoietin (EPO): Measuring this hormone in your blood. A low EPO level is a “minor criterion” for PV, whereas a high level might suggest a different cause ^[6].
• Excluding Secondary Causes: Ensuring your elevated red blood cells aren’t a natural reaction to something else, such as smoking, sleep apnea, or living at a high altitude ^[7].

Additionally, the pathologist will often check the marrow for reticulin fibrosis (scarring) ^[9]. Grading the amount of fibrosis helps your team assess the current state of your bone marrow and distinguish early PV from other closely related conditions, such as early myelofibrosis ^[10].